CNL Launches New Institute for Alpha Particle Research & Innovation

​

Canadian Nuclear Laboratories (CNL), Canada’s premier nuclear science and technology organization, announced that it is leading an international effort to launch Avenir, a virtual institute for alpha particle research and innovation. Avenir will facilitate worldwide research and collaboration, expand scientific understanding of alpha particles, and serve as an incubator for the development of commercial products and services.

As Canada’s national nuclear laboratory, CNL has an extensive science and technology program that includes alpha particle research. Among other projects, CNL is investigating the health impacts of alpha particle exposure, how to harness heat generated from alpha decay to power batteries for space travel, better detection techniques for environmental remediation and decommissioning activities, and manufacturing processes to produce alpha-emitting isotopes for industrial applications. With its specialized facilities, unique capabilities in the handling and research of radioisotopes, and the necessary regulatory licenses at its Chalk River campus, CNL will serve as Avenir’s parent company, offering members a broad range of resources to facilitate their research.

To read more please visit: https://globenewswire.com/news-release/2018/03/28/1454990/0/en/CNL-Launches-New-Institute-for-Alpha-Particle-Research-Innovation.html

Source: GlobeNewswire